Role of serotype and virulence determinants of Streptococcus pyogenes biofilm bacteria in internalization and persistence in epithelial cells in vitro

Streptococcus pyogenes causes a multitude of local and systemic infections, the most common being pharyngitis in children. Recurrent pharyngeal infections are common and are thought to be due to the re-emergence of intracellular GAS upon completion of antibiotic treatment. The role of colonizing biofilm bacteria in this process is not fully clear. Here, live respiratory epithelial cells were inoculated with broth-grown or biofilm bacteria of different M-types, as well as with isogenic mutants lacking common virulence factors. All M-types tested adhered to and were internalized into epithelial cells. Interestingly, internalization and persistence of planktonic bacteria varied significantly between strains, whereas biofilm bacteria were internalized in similar and higher numbers, and all strains persisted beyond 44 hours, showing a more homogenous phenotype. The M3 protein, but not the M1 or M5 proteins, was required for optimal uptake and persistence of both planktonic and biofilm bacteria inside cells. Moreover, the high expression of capsule and SLO inhibited cellular uptake and capsule expression was required for intracellular survival. Streptolysin S was required for optimal uptake and persistence of M3 planktonic bacteria, whereas SpeB improved intracellular survival of biofilm bacteria. Microscopy of internalized bacteria showed that planktonic bacteria were internalized in lower numbers as individual or small clumps of bacteria in the cytoplasm, whereas GAS biofilm bacteria displayed a pattern of perinuclear localization of bacterial aggregates that affected actin structure. Using inhibitors targeting cellular uptake pathways, we confirmed that planktonic GAS mainly uses a clathrin-mediated uptake pathway that also required actin and dynamin. Clathrin was not involved in biofilm internalization, but internalization required actin rearrangement and PI3 kinase activity, possibly suggesting macropinocytosis. Together these results provide a better understanding of the potential mechanisms of uptake and survival of various phenotypes of GAS bacteria relevant for colonization and recurrent infection.

[1]  R. Parton,et al.  Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics , 2021, Nature Nanotechnology.

[2]  Chihiro Aikawa,et al.  Intracellular Group A Streptococcus Induces Golgi Fragmentation To Impair Host Defenses through Streptolysin O and NAD-Glycohydrolase , 2020, mBio.

[3]  K. Riesbeck,et al.  A Role of Epithelial Cells and Virulence Factors in Biofilm Formation by Streptococcus pyogenes In Vitro , 2020, Infection and Immunity.

[4]  J. Duchin,et al.  Streptococcus pyogenes pbp2x Mutation Confers Reduced Susceptibility to β-lactam antibiotics. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  K. Riesbeck,et al.  HAMLET, a Protein Complex from Human Milk, Has Bactericidal Activity and Enhances the Activity of Antibiotics against Pathogenic Streptococci , 2019, Antimicrobial Agents and Chemotherapy.

[6]  Lars Malmström,et al.  A quantitative Streptococcus pyogenes–human protein–protein interaction map reveals localization of opsonizing antibodies , 2019, Nature Communications.

[7]  K. Kline,et al.  Streptococcus pyogenes Capsule Promotes Microcolony-Independent Biofilm Formation , 2019, bioRxiv.

[8]  V. Nizet,et al.  Recurrent group A Streptococcus tonsillitis is an immunosusceptibility disease involving antibody deficiency and aberrant TFH cells , 2019, Science Translational Medicine.

[9]  A. Hakansson,et al.  Growing and Characterizing Biofilms Formed by Streptococcus pneumoniae. , 2019, Methods in molecular biology.

[10]  J. Gern,et al.  Dynamics of Bacterial Colonization With Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis During Symptomatic and Asymptomatic Viral Upper Respiratory Tract Infection , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  J. C. Tsai,et al.  The ability of Group A streptococcus to adhere to immortalized human skin versus throat cell lines does not reflect their predicted tissue tropism. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  M. Rohde,et al.  Streptococcus pyogenes adhesion and colonization , 2016, FEBS letters.

[13]  D. Bessen Tissue tropisms in group A Streptococcus: what virulence factors distinguish pharyngitis from impetigo strains? , 2016, Current opinion in infectious diseases.

[14]  D. Holden,et al.  Cytosolic Replication of Group A Streptococcus in Human Macrophages , 2016, mBio.

[15]  Stevens Dl,et al.  Streptococcus pyogenes: Basic Biology to Clinical Manifestations , 2016 .

[16]  R. Lood,et al.  Localization-triggered bacterial pathogenesis. , 2015, Future microbiology.

[17]  K. Jansen,et al.  Group A Streptococcal Carriage and Seroepidemiology in Children up to 10 Years of Age in Australia , 2015, The Pediatric infectious disease journal.

[18]  E. Wald,et al.  The Group A Streptococcal Carrier State Reviewed: Still an Enigma. , 2014, Journal of the Pediatric Infectious Diseases Society.

[19]  Michael W Parker,et al.  A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. , 2014, The Journal of infectious diseases.

[20]  A. Helenius,et al.  Endocytosis of viruses and bacteria. , 2014, Cold Spring Harbor perspectives in biology.

[21]  M. Federle,et al.  Streptococcus pyogenes biofilm growth in vitro and in vivo and its role in colonization, virulence, and genetic exchange. , 2014, The Journal of infectious diseases.

[22]  S. Sriskandan,et al.  Current views of haemolytic streptococcal pathogenesis , 2014, Current opinion in infectious diseases.

[23]  M. Rohde,et al.  The M1 Protein of Streptococcus pyogenes Triggers an Innate Uptake Mechanism into Polarized Human Endothelial Cells , 2014, Journal of Innate Immunity.

[24]  V. Nizet,et al.  The globally disseminated M1T1 clone of group A Streptococcus evades autophagy for intracellular replication. , 2013, Cell host & microbe.

[25]  M. Wessels,et al.  Streptolysin O and its Co-Toxin NAD-glycohydrolase Protect Group A Streptococcus from Xenophagic Killing , 2013, PLoS pathogens.

[26]  L. Van Melderen,et al.  Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[27]  A. Hakansson,et al.  Sensitization of Staphylococcus aureus to Methicillin and Other Antibiotics In Vitro and In Vivo in the Presence of HAMLET , 2013, PloS one.

[28]  L. Björck,et al.  Antibody orientation at bacterial surfaces is related to invasive infection , 2012, The Journal of experimental medicine.

[29]  J. Musser,et al.  Human Disease Isolates of Serotype M4 and M22 Group A Streptococcus Lack Genes Required for Hyaluronic Acid Capsule Biosynthesis , 2012, mBio.

[30]  Christoph Dehio,et al.  Bartonella entry mechanisms into mammalian host cells , 2012, Cellular microbiology.

[31]  D. Kamei,et al.  The intracellular trafficking pathway of transferrin. , 2012, Biochimica et biophysica acta.

[32]  T. R. Peters,et al.  Detection of group A Streptococcus in tonsils from pediatric patients reveals high rate of asymptomatic streptococcal carriage , 2012, BMC Pediatrics.

[33]  H. Sakata,et al.  Biofilm formation or internalization into epithelial cells enable Streptococcus pyogenes to evade antibiotic eradication in patients with pharyngitis. , 2011, Microbial pathogenesis.

[34]  M. Wessels,et al.  Streptolysin O Inhibits Clathrin-Dependent Internalization of Group A Streptococcus , 2011, mBio.

[35]  G. Lindahl,et al.  Functional Dissection of Streptococcus pyogenes M5 Protein: the Hypervariable Region is Essential for Virulence , 2009, PloS one.

[36]  R. Lamont,et al.  Streptococcus Adherence and Colonization , 2009, Microbiology and Molecular Biology Reviews.

[37]  R. Valdivia,et al.  Leading a sheltered life: intracellular pathogens and maintenance of vacuolar compartments. , 2009, Cell host & microbe.

[38]  V. Nizet,et al.  Relationship between Expression of the Family of M Proteins and Lipoteichoic Acid to Hydrophobicity and Biofilm Formation in Streptococcus pyogenes , 2009, PloS one.

[39]  B. Hirst,et al.  Pili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin , 2007, Cellular microbiology.

[40]  B. Kreikemeyer,et al.  Characterization of Biofilm Formation by Clinically Relevant Serotypes of Group A Streptococci , 2006, Applied and Environmental Microbiology.

[41]  J. Carapetis,et al.  The global burden of group A streptococcal diseases. , 2005, The Lancet. Infectious diseases.

[42]  M. Wessels,et al.  Cytolysin-dependent evasion of lysosomal killing. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Lindahl,et al.  Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway , 2005, Molecular microbiology.

[44]  L. Niels-Christiansen,et al.  Cholera toxin entry into pig enterocytes occurs via a lipid raft- and clathrin-dependent mechanism. , 2005, Biochemistry.

[45]  S. Hamada,et al.  Autophagy Defends Cells Against Invading Group A Streptococcus , 2004, Science.

[46]  B. Kreikemeyer,et al.  The intracellular status of Streptococcus pyogenes: role of extracellular matrix-binding proteins and their regulation. , 2004, International journal of medical microbiology : IJMM.

[47]  S. Sela,et al.  Role of M3 protein in the adherence and internalization of an invasive Streptococcus pyogenes strain by epithelial cells. , 2003, FEMS immunology and medical microbiology.

[48]  E. Ziomek,et al.  Influence of group A streptococcal acid glycoprotein on expression of major virulence factors and internalization by epithelial cells. , 2003, Microbial pathogenesis.

[49]  I. Biswas,et al.  Identification of rocA, a Positive Regulator of covR Expression in the Group A Streptococcus , 2003, Journal of bacteriology.

[50]  L. Björck,et al.  Streptococcus pyogenes expressing M and M‐like surface proteins are phagocytosed but survive inside human neutrophils , 2003, Cellular microbiology.

[51]  M. Wessels,et al.  Cytotoxic Effects of Streptolysin O and Streptolysin S Enhance the Virulence of Poorly Encapsulated Group A Streptococci , 2003, Infection and Immunity.

[52]  M. Wessels,et al.  NAD+‐glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci , 2002, Molecular microbiology.

[53]  Steven D. Brown,et al.  In vitro bactericidal activity of daptomycin against staphylococci. , 2002, The Journal of antimicrobial chemotherapy.

[54]  S. Sela,et al.  Role of CsrR, Hyaluronic Acid, and SpeB in the Internalization of Streptococcus pyogenes M Type 3 Strain by Epithelial Cells , 2002, Infection and Immunity.

[55]  H. Courtney,et al.  Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci , 2002, Annals of medicine.

[56]  G. Bokoch,et al.  De novo formation of focal complex‐like structures in host cells by invading Streptococci , 2001, Molecular microbiology.

[57]  R. Kennedy,et al.  Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection , 2000, Cellular microbiology.

[58]  M. Cunningham,et al.  Pathogenesis of group A streptococcal infections. , 2000, Clinical microbiology reviews.

[59]  Malak Kotb,et al.  Genetic Relatedness and Superantigen Expression in Group A Streptococcus Serotype M1 Isolates from Patients with Severe and Nonsevere Invasive Diseases , 2000, Infection and Immunity.

[60]  S. Mousa,et al.  A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[61]  R. Fässler,et al.  Roles of integrins and fibronectin in the entry of Streptococcus pyogenes into cells via protein F1 , 1998, Molecular microbiology.

[62]  K. Berggård,et al.  Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor. , 1998, Journal of immunology.

[63]  P. Cleary,et al.  Streptococcus pyogenes Serotype M1 Encodes Multiple Pathways for Entry into Human Epithelial Cells , 1998, Infection and Immunity.

[64]  M. Wessels,et al.  Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. , 1998, The Journal of clinical investigation.

[65]  C. Lanz,et al.  Interaction of Bartonella henselae with endothelial cells results in bacterial aggregation on the cell surface and the subsequent engulfment and internalisation of the bacterial aggregate by a unique structure, the invasome. , 1997, Journal of cell science.

[66]  H. Courtney,et al.  Conversion of M serotype 24 of Streptococcus pyogenes to M serotypes 5 and 18: effect on resistance to phagocytosis and adhesion to host cells , 1997, Infection and immunity.

[67]  M. Rohde,et al.  The fibronectin-binding protein of Streptococcus pyogenes, SfbI, is involved in the internalization of group A streptococci by epithelial cells , 1997, Infection and immunity.

[68]  J. Vuopio‐Varkila,et al.  Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. , 1997, The Journal of infectious diseases.

[69]  J. Rheinwald,et al.  Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. , 1996, The Journal of clinical investigation.

[70]  G. Donnarumma,et al.  Invasion of cultured human cells by Streptococcus pyogenes. , 1995, Research in microbiology.

[71]  E. Chi,et al.  Group A streptococci efficiently invade human respiratory epithelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[72]  J. Goldberg,et al.  Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[73]  R. Kessler,et al.  Growth characteristics of group A streptococci in a new chemically defined medium , 1980, Infection and immunity.

[74]  E. Kaplan,et al.  The dynamics of streptococcal infections in a defined population of children: serotypes associated with skin and respiratory infections. , 1976, American journal of epidemiology.

[75]  L. Wannamaker Differences between streptococcal infections of the throat and of the skin (second of two parts). , 1970, The New England journal of medicine.

[76]  R. Lancefield Current knowledge of type-specific M antigens of group A streptococci. , 1962, Journal of immunology.